Background The mutation status of EGFR gene (exons 18~21) in Non-Small Cell Lung Cancer (NSCLC) is correlated with patients response towards EGFR-targeted m
The improved understanding of the processes that are central to the malignant transformation and tumor genesis has resulted in the development of several ne